Table 5.

Safety outcomes (group B subgroups)

	Total—n	Complications—n (%)	p
Group A (without BD)	155	19 (12.3)
Group B (All except ASA alone)	56	6 (10.7)	0.533
Group B (Anticoagulant only)	26	4 (15.4)	0.211
Group B (Antiplatelet single)	23	1 (4.3)	0.302
Group B (Anticoagulant + antiplatelet)	9	1 (11.1)	0.868
Group B (Dual antiplatelet)	6	0 (0.0)	0.405
Group B (DOAC users)	18	3 (16.7)	0.240
Group B (Hereditary BD only)	9	1 (11.1)	0.868

ASA aminosalicylic acid, DOAC direct oral anticoagulants, BD bleeding disorder

Tests used to compare variables between groups: Chi-square test